Envveno medical corporationNVNO.US Overview

US StockHealthcare

(No presentation for NVNO)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

NVNO Overall Performance

NVNO AI Analysis & Strategy

NVNO Recent Performance

1.74%

Envveno medical corporation

1.30%

Avg of Sector

0.61%

S&P500

NVNO PowerScanner

NVNO Key Information

NVNO Valuation Metrics

NVNO Earnings Table

NVNO Profile

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.